𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Endocrine properties of the testosterone 5α-reductase inhibitor turosteride (FCE 26073)

✍ Scribed by Di Salle, E.; Briatico, G.; Giudici, D.; Ornati, G.; Panzeri, A.

Book ID
122909763
Publisher
Elsevier Science
Year
1994
Tongue
English
Weight
824 KB
Volume
48
Category
Article
ISSN
0960-0760

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Effect of turosteride, a 5α-reductase in
Effect of turosteride, a 5α-reductase inhibitor, on the Dunning R3327 rat prostatic carcinoma
✍ Zaccheo, T.; Giudici, D.; di Salle, E. 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 351 KB 👁 1 views

BACKGROUND. Turosteride (FCE 26073) is a new, potent, and selective 5␣-reductase inhibitor. We have investigated its effect on tumor growth, organ weight, and serum hormone levels in rats bearing the androgen sensitive Dunning R3327 prostatic carcinoma. METHODS. Animals with tumor diameters of 0.5-1

Effect of early treatment of prostate ca
Effect of early treatment of prostate cancer with the 5α-reductase inhibitor turosteride in Dunning R3327 prostatic carcinoma in rats
✍ Zaccheo, Tiziana; Giudici, Donata; di Salle, Enrico 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 204 KB 👁 1 views

## Background: Turosteride, a selective 5alpha-reductase inhibitor, was reported to be effective in inhibiting the growth of established tumors in the dunning r3327 rat prostatic carcinoma model. we evaluated the preventive effect of turosteride when administered during the latency period in this p